| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/12/2005 | CN1563055A Nucleotide peculiar to 0-antigen of 0132 type bacillus coli |
| 01/12/2005 | CN1563054A Nucleotide peculiar to 0-antigen of 0130 type bacillus coli |
| 01/12/2005 | CN1563053A Nucleotide peculiar to 0-antigen of 0120 type bacillus coli |
| 01/12/2005 | CN1563052A Nucleotide peculiar to 0-antigen of 110 type bacillus coli |
| 01/12/2005 | CN1563051A Nucleotide peculiar to 0-antigen of 0100 type bacillus coli |
| 01/12/2005 | CN1563050A Nucleotide peculiar to 0-antigen of 095 type bacillus coli |
| 01/12/2005 | CN1563049A Nucleotide peculiar to 0-antigen of 088 type bacillus coli |
| 01/12/2005 | CN1563048A Nucleotide peculiar to 0-antigen of 066 type bacillus coli |
| 01/12/2005 | CN1563047A Nucleotide peculiar to 0-antigen of 061 type bacillus coli |
| 01/12/2005 | CN1563046A Nucleotide peculiar to 0-antigen of -56 type bacillus coli |
| 01/12/2005 | CN1563045A Nucleotide peculiar to 0-antigen of 051 type bacillus coli |
| 01/12/2005 | CN1563044A Nucleotide peculiar to 0-antigen of 049 type bacillus coli |
| 01/12/2005 | CN1563043A Nucleotide peculiar to 0-antigen of 043 type bacillus coli |
| 01/12/2005 | CN1563042A Nucleotide peculiar to 0-antigen of 041 type bacillus coli |
| 01/12/2005 | CN1563041A Nucleotide peculiar to 0-antigen of 039 type bacillus coli |
| 01/12/2005 | CN1563040A Nucleotide peculiar to 0-antige of 036 type bacillus coli |
| 01/12/2005 | CN1563039A Nucleotide peculiar to 0-antigen of 033 type bacillus coli |
| 01/12/2005 | CN1563038A Nucleotide peculiar to 0-antigen of 29 type bacillus coli |
| 01/12/2005 | CN1563037A Nucleotide peculiar to 0-antigen of 024 type bacillus coli |
| 01/12/2005 | CN1563036A Nucleotide peculiar to 0-antigen of 023 type bacillus coli |
| 01/12/2005 | CN1563035A Nucleotide peculiar to 0-antigen of 021 type bacillus coli |
| 01/12/2005 | CN1563034A Nucleotide peculiar to 0-antigen of 019 type bacillus coli |
| 01/12/2005 | CN1563033A Nucleotide peculiar to 0-antigen of 015 type bacillus coli |
| 01/12/2005 | CN1563032A Nucleotide peculiar to 0-antigen of 03 type bacillus coli |
| 01/12/2005 | CN1563031A Nucleotide peculiar to 0-antigen of 0114 type bacillus coil |
| 01/12/2005 | CN1562366A SARS nucleic acid vaccine and preparation method, application of S gene in coronavirus |
| 01/12/2005 | CN1562365A SARS vaccine of adenovirus carrier and preparation method, application of coronavirus S gene |
| 01/12/2005 | CN1562362A Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy |
| 01/12/2005 | CN1562354A Method for controlling mammal to give birth of female mammal based on H-Y antigen |
| 01/12/2005 | CN1561712A Method for cultivating ZW type lepidopteraus pest linkage balanced lethal system using molecule genetic label |
| 01/12/2005 | CN1561697A Method for establishing lily gene transforming receptor system |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184319C Chemosynthesized SARS virus S gene segement, its expression and application |
| 01/12/2005 | CN1184317C Modifying method and application of exilis protein gene |
| 01/12/2005 | CN1184316C Antisense oligonucleotide structure and use of cell propagation receptor IGFIK |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184314C Gene engineering preparation method of Chinese human being costimulation signal inhibition factor |
| 01/12/2005 | CN1184313C Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 01/12/2005 | CN1184310C Combined deletion 19 Kda, 55KDA, E1B code sequence recombination adenovirus construction body and its use |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1184232C Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition |
| 01/12/2005 | CN1184231C Wheat TaDREB, its code gene and method for culturing adverse-resistant plant |
| 01/12/2005 | CN1183968C Improved vacines |
| 01/11/2005 | USRE38687 Prerared from culture of microorganism producing said enzyme; for determination of creatine or creatinine in a sample using said enzyme |
| 01/11/2005 | US6842703 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 01/11/2005 | US6841722 Comprises nucleotide sequences coding shrunken (SSEI) protein for generating plant with improved storage and oil body biogenesis |
| 01/11/2005 | US6841721 Reduction of lignin biosynthesis in transgenic plants |
| 01/11/2005 | US6841720 Inducible promoters |
| 01/11/2005 | US6841719 Plant VDE genes and methods related thereto |
| 01/11/2005 | US6841718 Heterlogous gene derived from marine vascular plant; pathogen resistance, which may be conferred by stimulating zosteric acid biosynthesis |
| 01/11/2005 | US6841717 Methyl-D-erythritol phosphate pathway genes |
| 01/11/2005 | US6841662 Nucleotide sequences coding enzymatic polypeptide for use in the human dietics, cosmetics and therapeutics |
| 01/11/2005 | US6841659 Method for recovering proteins from the interstitial fluid of plant tissues |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method |
| 01/11/2005 | US6841540 Immunomodulation by genetic modification of dendritic cells and B cells |
| 01/11/2005 | US6841539 Oligonucleotide admixed with a topical penetration enhancer, isopropyl myristate |
| 01/11/2005 | US6841538 Combination therapy using nucleic acids and radio therapy |
| 01/11/2005 | US6841537 Combination therapy using nucleic acids and conventional drugs |
| 01/11/2005 | US6841535 Peptide-mediated transfection agents and methods of use |
| 01/11/2005 | US6841534 For inhibiting blood coagulation |
| 01/11/2005 | US6841383 Insertion of preferential nucleotide seqences into genome; ontain nucleotide sequences, incubate with cells, transform recover cell expressing preferential marker |
| 01/11/2005 | US6841382 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841379 Conductive microplate |
| 01/11/2005 | US6841378 Production of heterologouus proteins from Zygosaccharomyces bailii |
| 01/11/2005 | US6841376 Promoter-regulatory gene operons which repress transcription; use for regulating gene expression in a cell |
| 01/11/2005 | US6841375 Useful as a host cell for expression of recombinant DNA sequences; expression of homologous and heterologous genes in F. heparinum and the coupling of expression to secretion of biologically active polypeptides or protein |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | US6841369 DSP-4 dual specificity phosphatase |
| 01/11/2005 | US6841368 Fructotransferase which turns levan into difructose dianhydride IV |
| 01/11/2005 | US6841367 Human receptor tyrosine kinase, KDR |
| 01/11/2005 | US6841366 Biotin biosynthesis in bacillus subtilis |
| 01/11/2005 | US6841363 Preparation of capped mRNA |
| 01/11/2005 | US6841362 Melanoma differentiation associated gene-7 promoter and uses thereof |
| 01/11/2005 | US6841361 Methods of producing recombinant insulin from novel fused proteins |
| 01/11/2005 | US6841360 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/11/2005 | US6841359 Peptide for use as diagnostic tool in protein analysis |
| 01/11/2005 | US6841358 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins of vaccinating active principles |
| 01/11/2005 | US6841353 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 01/11/2005 | US6841352 Mating-based method for detecting protein—protein interaction |
| 01/11/2005 | US6841351 High-throughput transcriptome and functional validation analysis |
| 01/11/2005 | US6841349 Methods for the reduction of stutter in microsatellite amplification |
| 01/11/2005 | US6841347 In vivo construction of DNA libraries |
| 01/11/2005 | US6841258 For use in gene sequencing, monitoring gene expression, gene mapping, bacterial identification, drug discovery, and combinatorial chemistry |
| 01/11/2005 | US6841162 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841157 Wherein early genes are from a first type of papillomavirus and the late genes are from a second papillomavirus |
| 01/11/2005 | US6841155 Immunization against and treatment for infection by H. pylori |
| 01/11/2005 | US6841128 Four kinds of deoxynucleotide triphosphates (dNTP) are introduced to the reaction vessel in a designated order by pressurizing via capillaries or narrow grooves which connect reagent reservoir to vessel; smaller, efficient apparatus |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2337099C Enzymes for biopolymer production |
| 01/11/2005 | CA2337088C Methods and constructs for protein expression |
| 01/11/2005 | CA2291855C Reverse transcription method |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/11/2005 | CA2131984C Thermosensitive plasmide |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |